This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of breast, other/unspecified
CD2_INSITU_BREAST_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of breast, other/unspecified
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of breast, other/unspecified
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 471 | 471 | - |
| Unadjusted period prevalence (%) | 0.16 | 0.16 | - |
| Median age at first event (years) | 58.47 | 58.47 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 414
- Matched controls
- 4140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
+∞
323.0
301
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
5230.1
258.6
222
*
PJA12
NOMESCO Finland
Sentinel node biopsy
1094.5
206.4
185
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
173.5
154
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
172.2
153
*
HAC20
NOMESCO Finland
Total mastectomy
2103.1
154.3
140
*
115
Kela drug reimbursment
Breast cancer
+∞
154.0
138
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
212.5
152.4
150
11
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
116.3
106
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
111.6
102
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
103.6
95
*
HA1AA
NOMESCO Finland
X-ray mammography
26.7
96.4
137
75
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
37.5
92.6
119
44
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
80.9
75
*
L02BG04
ATC
letrozole; oral
309.1
77.3
76
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
865.8
75.7
72
*
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
+∞
75.3
70
*
H02AB02
ATC
dexamethasone; systemic
66.5
74.5
85
16
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
70.9
66
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
68.7
64
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
765.7
68.0
65
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
66.5
62
*
L02BA01
ATC
tamoxifen; oral
+∞
63.2
59
*
TQW20
NOMESCO Finland
Tatoe
+∞
59.9
56
*
A04AA02
ATC
granisetron; systemic, transdermal
655.9
59.2
57
*
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
+∞
57.7
54
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
41.2
43.4
54
15
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
41.3
39
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
5.1
41.1
157
442
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
40.3
38
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
39.2
37
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
+∞
38.1
36
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
36.0
34
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
36.0
34
*
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
+∞
34.9
33
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
34.9
33
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.9
34.4
72
86
HAB99
NOMESCO Finland
Other partial excision of mammary gland
35.0
34.3
44
14
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
61.2
33.9
39
7
ZZR10
NOMESCO Finland
Flap of skin and muscle
+∞
33.8
32
*
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
15.2
33.4
56
42
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
32.7
31
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
32.7
31
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
32.7
31
*
D05.0
ICD-10 Finland
Lobular carcinoma in situ
+∞
31.7
30
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
31.7
30
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
31.7
30
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
29.8
123
357
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
29.7
177
710
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
29.5
28
*
X76
ICPC
Malignant neoplasm breast female
+∞
29.5
28
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
28.5
27
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
28.5
27
*
Z31.5
ICD-10 Finland
Genetic counselling
11.0
28.2
55
57
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
149.7
27.0
28
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
26.3
25
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
53.7
25.6
30
6
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
25.3
24
*
N63
ICD-10 Finland
Unspecified lump in breast
6.8
24.9
66
113
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
24.2
23
*
9703
FHL
Breast resection
33.4
24.1
31
10
HAE99
NOMESCO Finland
Other reconstruction of breast
132.7
23.9
25
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
132.7
23.9
25
*
JN4BD
NOMESCO Finland
Extensive body CT
7.9
23.9
56
80
A04AD12
ATC
aprepitant; systemic
242.8
22.9
23
*
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
47.9
22.6
27
6
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
22.1
21
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
231.7
21.8
22
*
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
7.8
21.7
51
73
NK6AN
NOMESCO Finland
Total body bone isotope imaging
81.1
20.9
23
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
57.9
19.1
22
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
36.3
19.1
24
7
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
+∞
18.9
18
*
L02BG06
ATC
exemestane; oral
+∞
18.9
18
*
130
Kela drug reimbursment
Malignant tumour
+∞
18.9
18
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
73.4
18.9
21
*
HAD99
NOMESCO Finland
Other plastic operation on breast
73.4
18.9
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
198.6
18.7
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.3
18.3
33
29
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
69.8
17.9
20
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
17.8
17
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
19.7
17.5
26
14
WX702
NOMESCO Finland
Supraglottic ventilation device
5.3
16.9
53
111
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
16.8
16
*
L02BG03
ATC
anastrozole; oral
+∞
16.8
16
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
176.8
16.6
17
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.5
16.4
36
46
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
15.7
15
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
15.7
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.7
15
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
15.7
15
*
D05
ICD-10 Finland
Carcinoma in situ of breast
+∞
15.7
15
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
166.0
15.6
16
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
14.7
14
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
14.7
14
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
14.7
14
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
155.2
14.6
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
155.2
14.6
15
*
5702
FHL
Local lymph node removal (eg armpit, groin)
155.2
14.6
15
*
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
155.2
14.6
15
*
TQB05
NOMESCO Finland
Puncture of skin of trunk
44.1
14.2
17
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
13.6
13
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
13.6
13
*
9706
FHL
Ablation mammae, includes axillary exploration
+∞
13.6
13
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
144.5
13.5
14
*
WX402
NOMESCO Finland
General anaesthesia
3.1
13.0
80
300
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
12.6
12
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.3
12.4
47
121
HAD40
NOMESCO Finland
Mastopexy
38.8
12.3
15
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
31.0
11.7
15
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
11.7
189
1179
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
XX1XN
NOMESCO Finland
Other isotope examination
+∞
11.5
11
*
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
10.9
116
593
9702
FHL
Breast exploration and possible tumor removal
7.0
10.9
26
39
QBA00
NOMESCO Finland
Puncture of skin of trunk
61.6
10.7
12
*
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
112.7
10.5
11
*
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
+∞
10.5
10
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
10.5
10
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.5
10
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
33.5
10.4
13
*
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
7.5
10.1
23
32
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.7
10.1
34
78
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
9.9
163
1005
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
26.7
9.9
13
5
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
102.3
9.5
10
*
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
+∞
9.4
9
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
9.4
9
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
9.4
9
*
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
9.4
9
*
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
+∞
9.4
9
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
9.4
9
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.5
9.2
23
37
HAA10
NOMESCO Finland
Biopsy of mammary gland
10.4
9.1
17
17
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
37.6
9.1
11
*
ZXE00
NOMESCO Finland
One hour or less
1.9
8.9
174
1130
TQW99
NOMESCO Finland
Other minor procedure on skin
5.1
8.8
27
56
WZC30
NOMESCO Finland
Teaching
3.0
8.7
53
196
JN4CD
NOMESCO Finland
Very extensive body CT
9.3
8.6
17
19
HA1AE
SPAT
NA
7.6
8.5
19
26
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
28.2
8.5
11
*
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
28.2
8.5
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
91.8
8.4
9
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
91.8
8.4
9
*
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
91.8
8.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.4
8
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
PJ5YQ
NOMESCO Finland
NA
+∞
8.4
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
HAD20
NOMESCO Finland
Liposuction of breast
+∞
8.4
8
*
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
34.1
8.1
10
*
WF002
NOMESCO Finland
Radical radiotherapy
45.8
7.7
9
*
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
25.5
7.6
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
81.5
7.4
8
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
HA1SA
NOMESCO Finland
Expansion mammography
+∞
7.3
7
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
7.3
7
*
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
+∞
7.3
7
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
+∞
7.3
7
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
7.3
7
*
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
20.4
7.2
10
5
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
40.7
6.8
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
40.7
6.8
8
*
D24
ICD-10 Finland
Benign neoplasm of breast
5.3
6.7
19
37
X21
ICPC
Breast sympt/compl female other
6.1
6.7
17
29
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.5
6.6
11
9
HA1AA
SPAT
NA
5.2
6.6
19
38
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
6.5
26
72
9719
FHL
Other measure in this category
70.9
6.4
7
*
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
14.6
6.4
10
7
ZXA05
NOMESCO Finland
Left side
1.8
6.4
121
761
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
6.3
6
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
6.3
6
*
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
+∞
6.3
6
*
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
+∞
6.3
6
*
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
+∞
6.3
6
*
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
+∞
6.3
6
*
L01XE33
ATC
[U] palbociclib; oral
+∞
6.3
6
*
1501
Kela drug reimbursment
Palbociclib
+∞
6.3
6
*
394
Kela drug reimbursment
Palbociclib
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
A04AA01
ATC
ondansetron; systemic, rectal
4.4
6.0
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
133
107
16.93
142.13
1.4
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
80
48
19.87
98.36
1.4
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
121
282
5.43
51.00
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
251
1406
2.68
24.37
2.5
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
234
1364
2.42
19.58
3.6
2.1
mmol/l
2.4
2.4
0.26
216
1132
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
71
224
3.55
19.08
5.0
1.4
ug/l
4.3
2.6
1.42
60
176
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
24
7
36.01
19.07
4.9
1.0
u/ml
31.0
17.6
—
24
7
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
390
3014
2.71
15.43
9.1
5.2
u/l
73.8
76.0
0.92
362
2763
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
92
382
2.75
15.31
3.1
3.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
276
1870
2.15
14.52
7.2
3.3
umol/l
9.5
10.6
1.39
257
1739
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
79
317
2.79
13.97
4.1
2.6
mmol/l
1.2
1.2
0.43
62
257
(3018418) pH of Serum or Plasma
193
1205
2.02
11.97
4.4
3.0
ph
7.4
7.4
0.59
53
196
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
239
1654
1.90
10.58
3.6
3.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
11
10.22
9.57
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
149
914
1.92
9.27
6.8
4.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
67
303
2.41
9.16
3.9
4.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
60
4.16
8.89
1.4
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
279
2115
1.78
8.44
10.0
6.5
e9/l
3.5
4.1
6.23
258
1833
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
49
214
2.44
7.21
2.1
1.5
u/ml
22.0
21.6
0.02
44
204
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
5
20.38
7.16
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
157
1048
1.75
7.11
2.1
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
241
1827
1.65
6.66
5.0
4.4
mmol/l
1.2
1.2
0.05
208
1605
(3021589) Normoblasts [#/volume] in Blood
222
1680
1.61
5.96
10.6
8.5
e9/l
0.0
0.0
0.04
183
1376
(3012095) Magnesium [Moles/volume] in Serum or Plasma
88
537
1.79
5.28
2.4
2.2
mmol/l
0.8
0.8
0.36
80
490
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
253
2023
1.54
5.04
5.9
4.9
mmol/l
1.2
1.2
0.70
183
1715
(1616796) Gas panel - Central venous blood
19
63
3.10
4.72
3.3
3.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
23
95
2.49
3.86
3.4
1.8
u/ml
241.8
77.5
0.33
18
81
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
5
12.13
3.77
3.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
171
1319
1.47
3.74
3.2
3.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
49
281
1.83
3.60
2.0
1.8
g/l
0.2
0.2
1.52
42
264
(3002385) Erythrocyte distribution width [Ratio]
363
3252
1.51
3.44
19.0
14.7
%
13.6
13.7
0.28
351
3166
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
112
809
1.50
3.35
2.8
2.2
mmol/l
2.5
2.5
0.02
106
699
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
143
1821
0.69
3.32
2.0
2.0
pmol/l
99.5
99.3
0.02
67
828
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
417
3867
1.68
3.26
16.0
11.0
ml/min/173m2
77.8
76.4
0.89
369
3080
(3044889) 12 lead EKG panel
331
2926
1.44
3.24
4.0
3.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
161
1256
1.43
3.23
4.2
5.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
57
355
1.69
3.17
2.8
1.9
umol/l
5.7
5.2
0.16
43
305
(3020682) Albumin/Creatinine [Ratio] in Urine
106
1410
0.68
3.06
3.9
3.7
mg/mmol
10.4
6.7
0.30
51
782
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
111
818
1.47
2.99
2.1
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
111
828
1.45
2.79
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
17
73
2.38
2.68
2.8
2.3
%
16.6
16.4
0.07
12
33
(40761535) Cells panel - Urine sediment
18
366
0.47
2.61
2.2
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
383
3535
1.45
2.52
16.3
13.8
%
39.4
38.9
0.68
250
2337
(3009508) Creatinine [Moles/volume] in Urine
107
1380
0.71
2.51
3.0
2.9
mmol/l
5.5
6.3
1.72
81
1160
(3012516) Albumin [Mass/volume] in Urine
103
1336
0.71
2.49
2.8
3.0
mg/l
859.0
204.6
0.36
50
731
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
70
2.33
2.44
2.5
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
198
1660
1.33
2.40
4.3
3.3
g/l
36.3
35.8
0.71
179
1529
(3012501) Base excess in Blood by calculation
16
71
2.30
2.37
3.0
4.1
mmol/l
2.3
3.4
—
10
55
(3013290) Carbon dioxide [Partial pressure] in Blood
16
71
2.30
2.37
3.0
4.2
kpa
4.8
5.2
1.45
16
71
(3027315) Oxygen [Partial pressure] in Blood
16
71
2.30
2.37
3.0
4.2
kpa
8.4
8.2
0.13
16
71
(40761511) CBC panel - Blood by Automated count
436
4148
1.69
2.35
14.7
11.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
571
0.60
2.30
4.7
6.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
371
3950
0.71
2.25
5.1
6.0
mmol/mol
39.2
39.9
0.92
310
3633
(3019150) Specific gravity of Urine by Refractometry
69
943
0.69
2.22
3.7
4.5
kg/l
1.0
1.0
—
7
139
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
24
3.37
2.19
5.9
1.5
nmol/l
3.1
3.2
—
8
24
(3021901) Oxygen saturation in Capillary blood
13
55
2.40
2.14
2.6
2.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
110
862
1.36
2.05
3.1
3.0
%
94.9
93.4
0.21
105
834
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
10
38
2.67
2.02
1.2
1.1
u/ml
0.1
3.2
—
5
12
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
72
2.12
1.88
2.3
2.9
e9/l
4.3
4.3
0.02
15
72
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
53
0.00
1.88
0.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
73
2.09
1.82
2.9
3.2
%
59.5
59.9
0.03
15
73
(3000012) Reticulocyte production index
6
18
3.36
1.75
3.2
1.9
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
11
228
0.47
1.73
2.5
2.4
g/l
127.5
127.4
0.01
11
218
(3023323) Follitropin [Units/volume] in Serum or Plasma
21
118
1.82
1.73
1.4
1.2
iu/l
38.8
33.9
0.28
21
105
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
24
2.94
1.73
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
108
867
1.32
1.71
1.5
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
14
264
0.52
1.68
2.2
2.3
kpa
3.6
4.6
2.75
14
255
(3012544) pH of Venous blood
20
337
0.58
1.65
2.4
2.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
19
323
0.57
1.62
2.4
2.9
kpa
6.2
5.9
1.12
19
313
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
32
2.53
1.60
1.4
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
175
1509
1.25
1.57
10.9
8.3
inr
1.2
1.2
0.26
76
433
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
15
3.36
1.52
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
56
416
1.39
1.46
1.3
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
36
246
1.50
1.45
1.4
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
16
3.15
1.44
1.4
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
16
3.15
1.44
1.4
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
101
824
1.29
1.42
4.4
3.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
408
4229
0.74
1.40
5.2
5.4
mmol/l
2.9
2.8
1.52
332
3863
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
161
0.49
1.38
1.6
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
136
1159
1.24
1.33
3.3
2.4
u/l
27.8
29.9
0.46
131
1103
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
131
0.45
1.30
2.3
2.0
ug/l
897.2
1791.6
—
6
118
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
48
2.11
1.28
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
72
569
1.31
1.28
1.8
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
72
569
1.31
1.28
2.1
2.7
e6/l
2.4
4.5
1.50
37
287
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
92
1.77
1.26
1.7
2.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
221
1.48
1.25
1.9
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
36
2.24
1.25
3.6
2.2
pg
33.4
32.2
—
8
36
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
399
4138
0.77
1.24
4.6
4.9
mmol/l
5.8
5.9
0.57
315
3754
(3019832) Treponema pallidum Ab [Presence] in Serum
7
143
0.48
1.22
1.1
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
68
849
0.77
1.22
2.0
1.7
nmol/l
1197.5
1213.9
0.04
41
627
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
213
1917
1.20
1.19
2.3
2.3
nmol/l
81.8
81.3
0.10
184
1686
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
53
405
1.35
1.19
1.7
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
343
0.65
1.19
3.3
2.1
ml/min/173m2
64.2
65.7
—
8
138
(3003458) Phosphate [Moles/volume] in Serum or Plasma
59
460
1.32
1.16
3.2
3.4
mmol/l
1.0
1.0
0.23
52
407
(3020630) Protein [Mass/volume] in Serum or Plasma
44
328
1.38
1.16
2.3
1.4
g/l
68.8
67.6
0.45
38
293
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.4
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
380
3957
0.79
1.15
3.9
4.3
mmol/l
1.2
1.3
0.94
304
3562
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
45
338
1.37
1.13
2.2
1.9
u/l
29.4
36.2
0.83
37
273
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
26
178
1.49
1.08
3.8
6.1
mmol/l
24.4
25.5
0.67
26
178
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
401
4143
0.78
1.06
4.5
4.8
mmol/l
4.9
4.8
0.79
327
3802
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
75
1.75
1.03
1.1
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
117
1348
0.82
1.03
2.0
2.1
u/l
138.0
160.4
0.36
106
1278
(3024263) Appearance of Synovial fluid
5
22
2.29
1.03
2.4
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
98
828
1.23
1.03
4.1
4.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
86
1021
0.81
1.02
1.5
1.6
nmol/l
19.4
22.5
1.22
68
863
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
407
1.31
1.02
1.7
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
411
0.71
1.01
1.5
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
61
1.82
0.99
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
61
1.82
0.99
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
182
1.45
0.98
1.1
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
29
0.00
0.98
0.0
2.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
29
0.00
0.98
0.0
1.7
—
10.4
—
0
29
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
575
0.76
0.98
5.1
4.9
%
35.0
34.1
0.24
27
366
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
398
4107
0.80
0.95
4.5
4.8
mmol/l
1.6
1.6
0.96
323
3747
(3007853) Bacteria identified in Skin by Aerobe culture
49
385
1.30
0.94
1.5
1.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
195
1774
1.17
0.91
4.9
6.0
%
8.8
8.4
0.71
184
1631
(44813793)
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
79
1.66
0.89
2.6
3.1
mmol/l
23.9
26.1
1.69
13
70
(3041096) Erythrocytes [Presence] in Urine by Automated
120
1051
1.19
0.88
3.7
3.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
60
489
1.26
0.88
1.9
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
20
286
0.69
0.87
3.5
4.6
mmol/l
1.2
1.4
0.88
20
276
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
43
1.87
0.87
1.4
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
188
1711
1.16
0.87
4.7
5.8
%
0.7
0.7
0.81
178
1560
(3027273) Bicarbonate [Moles/volume] in Venous blood
11
179
0.61
0.86
2.5
2.5
mmol/l
26.0
25.7
0.16
11
171
(3002030) Lymphocytes/100 leukocytes in Blood
198
1810
1.16
0.86
4.8
5.9
%
27.6
28.9
0.84
187
1659
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
256
2386
1.16
0.86
2.9
2.8
u/l
45.1
41.8
0.25
222
2180
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
85
990
0.83
0.84
2.2
2.2
mg/l
2.6
3.0
1.04
66
832
(3001122) Ferritin [Mass/volume] in Serum or Plasma
155
1713
0.86
0.83
2.5
2.6
ug/l
110.4
93.6
0.79
131
1556
(3013707) Erythrocyte sedimentation rate by Westergren method
329
3130
1.17
0.83
3.9
4.4
mm/h
13.6
12.9
0.32
284
2875
(3000991) Gas panel - Venous blood
18
258
0.69
0.81
4.0
5.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
114
1002
1.18
0.80
2.7
2.9
—
—
—
0
0
(3020891) Body temperature
9
148
0.60
0.80
4.4
3.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
61
505
1.24
0.79
22.5
23.9
inr
1.4
1.3
—
6
73
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
66
1.68
0.79
1.4
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
299
2829
1.16
0.79
4.1
4.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
435
4252
1.30
0.78
15.8
14.2
mmol/l
139.9
139.9
0.00
413
4134
(3014051) Protein [Presence] in Urine by Test strip
17
116
1.48
0.75
1.6
2.3
—
—
—
0
0
(1002224) Polysomnography panel
8
134
0.59
0.74
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
135
0.59
0.74
3.1
3.3
—
—
—
0
0
(4024509)
9
55
1.65
0.74
1.4
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
192
1769
1.14
0.73
4.7
5.8
%
2.7
2.9
0.93
178
1619
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
84
1.56
0.72
4.3
2.4
u/ml
0.3
0.4
—
8
56
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
11
68
1.63
0.72
2.8
2.0
g/l
3.4
3.3
0.05
11
63
(3052851) Hemolysis interference index of Serum or Plasma
16
109
1.48
0.72
3.8
3.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
26
1.93
0.71
1.0
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
73
626
1.20
0.69
2.1
2.5
e6/l
1.1
1.6
0.86
38
345
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
42
1.68
0.68
1.4
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
5
27
1.86
0.68
1.0
1.2
g/l
30.4
26.6
—
5
22
(3023103) Potassium [Moles/volume] in Serum or Plasma
435
4262
1.27
0.67
16.0
14.3
mmol/l
3.9
3.9
0.32
410
4134
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
43
1.64
0.67
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
44
1.60
0.65
1.3
1.0
—
—
—
0
0
(4094501)
8
127
0.62
0.65
1.1
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
193
1791
1.13
0.64
4.7
5.7
%
56.9
56.6
0.15
182
1646
(3002582) Erythrocytes [#/volume] in Urine
122
1098
1.15
0.64
2.7
3.1
e6/l
20.1
50.6
1.38
85
843
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
313
0.75
0.64
1.2
1.2
iu/ml
92.5
145.1
—
6
130
(3030467) Casts [#/volume] in Urine by Automated count
113
1013
1.15
0.63
2.7
3.0
e6/l
0.5
0.4
0.17
79
777
(4010399)
26
334
0.77
0.63
1.3
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
20
0.00
0.60
0.0
2.2
—
41.2
—
0
20
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.3
—
30.6
—
0
21
(3045716) Anion gap in Serum or Plasma
0
21
0.00
0.60
0.0
2.5
—
9.2
—
0
15
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
276
0.75
0.60
1.0
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
10
150
0.66
0.59
1.4
1.7
mg/l
2.5
2.2
—
10
109
(3022806) Fractional oxyhemoglobin in Capillary blood
8
53
1.52
0.58
1.7
1.9
%
88.4
89.6
—
8
53
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
23.7
—
0
23
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
2.7
—
33.0
—
0
16
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
23
0.00
0.58
0.0
1.2
—
5.9
—
0
23
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
35
1.72
0.58
2.0
1.6
u/ml
4.3
109.1
—
6
35
(3017181) Myelocytes/100 leukocytes in Blood
37
302
1.24
0.57
3.2
3.9
%
1.5
0.7
0.60
13
47
(3051611) Lipemic interference index of Serum or Plasma
6
36
1.68
0.57
5.3
2.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
35
285
1.25
0.56
3.3
4.0
%
0.0
2.1
—
10
42
(3040151) Glucose [Moles/volume] in Capillary blood
6
37
1.63
0.55
1.2
1.6
mmol/l
7.7
7.0
—
6
28
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.5
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
250
0.75
0.55
1.2
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
796
0.86
0.54
3.4
4.0
ng/l
281.1
363.5
0.12
53
619
(3044941) Cell count panel - Synovial fluid
11
74
1.50
0.54
1.8
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
35
287
1.24
0.53
2.9
3.7
%
1.3
0.4
—
10
40
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
39
1.55
0.53
6.8
1.8
u/ml
81.5
15.8
—
6
39
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
39
1.55
0.53
1.5
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
180
0.71
0.52
1.1
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
313
0.79
0.51
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
29
235
1.25
0.49
2.4
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
256
0.77
0.49
2.2
2.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
45
1.56
0.49
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
109
0.64
0.49
4.3
4.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
35
291
1.22
0.48
3.4
4.0
%
0.2
0.0
0.93
13
43
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.47
1.6
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
1005
0.88
0.47
2.9
3.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
49
1.43
0.46
1.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
87
960
0.89
0.45
1.6
1.7
pmol/l
464.2
24084227.0
1.06
56
764
(3025130) Human papilloma virus identified in Specimen
7
50
1.41
0.45
1.0
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
406
3979
1.15
0.45
14.9
12.0
mg/l
18.6
19.8
0.39
318
3041
(3000764) Benzodiazepines [Presence] in Urine
7
51
1.38
0.44
2.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
51
1.38
0.44
2.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
51
1.38
0.44
2.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
51
1.38
0.44
2.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
802
0.88
0.43
1.3
1.3
u/ml
23.2
13.2
0.30
25
307
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
390
3979
0.88
0.43
5.4
5.5
mu/l
1.8
2.2
0.68
328
3624
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
5
32
1.57
0.42
1.2
1.3
u/l
—
55.5
—
0
11
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
96
877
1.12
0.42
1.5
1.6
mg/l
1.5
1.0
0.27
74
668
(3048689) Calprotectin [Mass/mass] in Stool
43
496
0.85
0.42
1.9
1.9
ug/g
77.9
140.4
1.88
31
387
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
282
0.81
0.41
1.7
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
15
0.00
0.41
0.0
1.6
—
25.2
—
0
9
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
217.1
—
0
16
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
438
4321
1.19
0.41
12.5
9.1
u/l
24.8
22.9
0.51
410
4134
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
16
123
1.31
0.41
2.2
1.3
g/l
0.0
0.0
0.00
16
114
(3020564) Creatinine [Moles/volume] in Serum or Plasma
436
4300
1.19
0.41
18.3
14.0
umol/l
69.5
70.7
0.66
436
4300
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
15.8
—
754.5
—
0
17
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
26
214
1.23
0.40
1.2
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
20.4
—
1705.4
—
0
18
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
32
270
1.20
0.39
1.3
1.3
—
52.2
—
0
12
(3015171) Extractable nuclear Ab [Units/volume] in Serum
21
169
1.25
0.39
1.1
1.3
—
0.9
—
0
13
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
16
124
1.30
0.39
2.2
1.3
g/l
0.0
0.0
0.00
16
115
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
9.8
—
0
19
(3006653) Thiamine [Moles/volume] in Blood
0
19
0.00
0.39
0.0
1.4
—
133.6
—
0
19
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
37
1.36
0.37
1.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
35
301
1.18
0.36
2.3
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
76
0.65
0.36
1.4
1.2
nmol/l
0.5
0.7
—
5
71
(3044290) Cell count panel - Cerebral spinal fluid
5
79
0.63
0.35
1.4
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
80
0.62
0.35
2.0
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
24
200
1.21
0.34
1.5
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
46
1.31
0.33
1.3
1.0
—
—
—
0
0
(4306422)
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
16
128
1.26
0.32
2.2
1.4
g/l
0.0
0.0
0.50
16
118
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
99
0.70
0.31
1.6
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
84
1.32
0.30
7.2
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
51
459
1.12
0.30
1.3
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
56
1.25
0.29
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
56
508
1.12
0.29
2.1
2.3
g/l
2.2
2.4
2.68
45
468
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
195
0.81
0.29
1.5
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
51
460
1.12
0.29
2.1
2.4
%
22.3
22.0
0.04
41
387
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
205
0.82
0.28
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
30
343
0.87
0.28
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
94
1.28
0.28
1.8
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
168
1.20
0.27
2.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
95
1.27
0.26
1.6
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
115
1087
1.08
0.26
3.8
4.4
estimate
0.0
0.0
0.00
48
343
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
170
0.82
0.25
1.5
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
213
2201
0.94
0.25
2.8
2.6
—
—
—
0
0
(3013512) EKG study
133
1268
1.07
0.24
3.7
3.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
447
4435
1.15
0.24
22.5
18.1
fl
91.4
91.2
0.37
431
4357
(3026361) Erythrocytes [#/volume] in Blood
447
4436
1.15
0.23
22.6
18.2
e12/l
4.4
4.4
1.38
427
4287
(3010813) Leukocytes [#/volume] in Blood
447
4436
1.15
0.23
22.6
18.2
e9/l
6.2
6.5
4.24
427
4284
(3000963) Hemoglobin [Mass/volume] in Blood
447
4436
1.15
0.23
22.6
18.3
g/l
130.8
132.5
2.14
431
4359
(3035941) MCH [Entitic mass]
447
4436
1.15
0.23
22.4
18.1
pg
30.2
30.2
0.02
431
4358
(3007461) Platelets [#/volume] in Blood
447
4436
1.15
0.23
22.6
18.2
e9/l
255.1
261.4
1.55
431
4302
(3008295) Osmolality of Serum or Plasma
5
39
1.29
0.23
1.4
1.6
mosm/kgh2o
271.0
269.1
—
5
29
(3032773) Endomysium IgG Ab [Titer] in Serum
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
38
419
0.90
0.22
4.0
3.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
182
1.16
0.21
2.8
3.1
mmol/l
1.5
2.3
0.56
14
139
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
1.8
—
0
10
(40768446) Kidney Pathology biopsy report
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
103
0.77
0.21
1.9
1.7
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
12
145
0.82
0.21
1.9
1.7
g/l
1.6
1.6
—
7
130
(3042631) Mycobacterium sp identified in Specimen
5
43
1.16
0.21
2.0
2.7
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
1.3
—
0
8
(3005033) Fetal Nuchal fold Thickness US
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(4198724)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
10
80
1.26
0.20
1.4
1.9
%
143.7
182.5
—
10
74
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
128
1226
1.06
0.20
1.6
1.7
mmol/l
1.3
1.3
0.36
81
1019
(3022689) Creatine [Moles/volume] in Urine
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
14
0.00
0.20
0.0
1.0
—
1105.4
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
323
0.89
0.20
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
154
0.84
0.19
1.0
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
214
1.13
0.18
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
41
378
1.09
0.17
2.2
3.1
ng/l
63.8
79.6
0.98
29
329
(3020961) Endomysium IgA Ab [Titer] in Serum
16
184
0.86
0.17
1.0
1.2
—
136.5
—
0
10
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
76
800
0.94
0.16
1.2
1.3
iu/ml
55.8
41.3
0.16
18
268
(3035350) Ketones [Presence] in Urine by Test strip
208
2029
1.05
0.16
3.5
4.1
estimate
0.0
0.0
0.00
48
346
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
69
1.16
0.16
1.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
73
1.10
0.15
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
36
334
1.08
0.14
1.8
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
75
785
0.95
0.14
2.4
2.5
e6/l
6.7
8.8
0.31
64
701
(3009343) pH of Capillary blood
21
189
1.12
0.14
2.8
3.3
ph
7.4
7.4
0.44
11
29
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
100
0.80
0.13
1.4
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
201
0.89
0.13
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
92
954
0.96
0.12
2.2
2.1
umol/l
316.2
5562.2
3.66
72
800
(3037756) Immunofixation for Serum or Plasma
10
85
1.18
0.12
1.7
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
128
1246
1.04
0.11
1.8
2.1
u/l
50.4
59.6
2.30
107
1122
(3037522) Nuclear Ab [Titer] in Serum
61
584
1.05
0.11
1.2
1.3
titre
506.7
670.2
0.37
18
151
(3013826) Glucose [Moles/volume] in Serum or Plasma
232
2284
1.03
0.10
3.8
3.7
mmol/l
6.4
6.7
1.56
223
2120
(3018095) Leukocytes [#/volume] in Urine
137
1337
1.03
0.10
3.2
3.6
e6/l
49.1
129.8
2.26
91
925
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
26
279
0.93
0.10
2.8
3.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
15
135
1.11
0.10
1.1
1.3
—
2.5
—
0
17
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
352
3490
1.03
0.09
4.6
4.5
pmol/l
15.2
14.9
1.04
290
3180
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
176
0.91
0.09
1.1
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
28
299
0.93
0.09
4.3
2.5
e9/l
77.0
71.5
0.31
22
228
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
155
1.10
0.09
1.6
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
237
0.92
0.09
1.1
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
61
0.82
0.08
1.2
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
63
0.79
0.08
1.4
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
58
559
1.04
0.08
2.3
2.3
umol/l
12.3
13.1
0.36
49
511
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
127
1.11
0.08
1.9
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
154
1567
0.97
0.08
3.9
4.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
208
2052
1.02
0.07
4.7
5.4
estimate
0.0
0.0
0.00
47
337
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
70
0.86
0.07
1.2
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
70
0.86
0.07
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
72
0.83
0.07
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
72
0.83
0.07
1.2
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
74
1.08
0.07
1.1
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
77
1.04
0.07
1.8
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
122
0.90
0.07
1.6
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
94
0.85
0.06
1.1
1.2
—
1555.0
—
0
6
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
103
0.87
0.06
1.0
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
135
1329
1.02
0.06
2.7
3.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
28
267
1.05
0.05
1.2
1.2
u/ml
117.5
181.4
0.77
23
244
(3009261) Glucose [Presence] in Urine by Test strip
208
2060
1.02
0.05
3.6
4.1
estimate
0.0
0.0
0.80
47
341
(3026008) Bacteria identified in Urine by Culture
152
1501
1.02
0.05
3.0
3.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
120
0.91
0.05
2.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
130
0.92
0.04
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
130
1.08
0.04
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
130
1.08
0.04
1.1
1.2
—
—
—
0
0
(3015736) pH of Urine
160
1617
0.98
0.04
3.2
3.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
195
1933
1.02
0.04
4.6
5.6
e9/l
0.0
0.0
1.66
170
1655
(3007164) IgA [Mass/volume] in Serum or Plasma
74
753
0.98
0.03
1.7
1.3
g/l
2.0
2.4
1.25
35
414
(3001019) Free T4 and TSH panel - Serum or Plasma
17
179
0.95
0.03
1.6
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
132
1.06
0.02
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
30
292
1.03
0.02
1.6
1.5
%
1.2
1.3
0.59
24
256
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
137
0.95
0.01
1.5
1.7
—
120.0
—
0
8
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
167
0.96
0.01
7.8
7.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
193
1921
1.01
0.01
4.6
5.6
e9/l
0.6
0.6
0.00
169
1647
(3013115) Eosinophils [#/volume] in Blood
202
2011
1.01
0.01
4.7
5.8
e9/l
0.2
0.2
0.90
175
1761
(3019060) Gas panel - Arterial blood
23
223
1.03
0.01
4.9
4.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
617
0.99
0.01
1.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
166
0.96
0.00
1.1
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
37
376
0.98
0.00
1.8
1.8
nmol/l
370.7
360.1
0.11
32
340
(40768797) Stomach Pathology biopsy report
63
624
1.01
0.00
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
127
1276
0.99
0.00
2.5
2.7
ng/l
1015.8
1124.0
0.21
104
1061
(3019198) Lymphocytes [#/volume] in Blood
197
1964
1.01
0.00
4.7
5.6
e9/l
1.7
1.9
2.67
171
1717
(46235355) HIV 1 and 2 tests - Meaningful Use set
36
355
1.02
0.00
1.2
1.4
—
—
—
0
0
(4034850)
15
153
0.98
0.00
5.1
9.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
26
257
1.01
0.00
2.1
2.8
pmol/l
4.6
4.5
0.23
18
218
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
122
0.98
0.00
2.0
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
109
1.01
0.00
1.1
1.3
—
10.3
—
0
10
(3030981) Hyaline casts [#/volume] in Urine by Automated count
18
179
1.01
0.00
1.4
2.4
e6/l
0.2
0.2
0.04
18
172
(3003396) Base excess in Arterial blood by calculation
39
391
1.00
0.00
4.7
5.3
mmol/l
2.0
1.6
0.45
30
313
(3026782) Osmolality of Urine
72
719
1.00
0.00
2.4
2.7
mosm/kgh2o
482.5
502.5
0.31
59
619
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
93
933
1.00
0.00
1.2
1.3
u/ml
0.6
2.3
2.07
22
243
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
157
1575
1.00
0.00
3.5
3.6
ng/l
29.1
90.9
0.71
117
1080
(3023419) Bacteria identified in Sputum by Culture
5
53
0.94
0.00
2.2
3.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.9
—
0.8
—
0
8
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
51
0.98
0.00
1.6
2.1
mmol/l
4.0
4.0
—
5
51
(4015189)
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
62
0.97
0.00
1.2
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
16.6
—
0
7
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
1.3
—
0.7
—
0
7
(3035285) Chloride [Moles/volume] in Venous blood
5
51
0.98
0.00
1.6
2.1
mmol/l
103.8
105.7
—
5
51
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
101.7
—
0
7
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
11.2
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
92
0.98
0.00
1.2
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
70.4
—
0
5
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
86
0.93
0.00
2.0
1.7
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
59.0
—
0
5
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
2.5
—
1.2
—
0
8
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
1.6
—
0
8
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
16.4
—
0
6
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
51
0.98
0.00
1.6
2.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST_NOS_EXALLC – Carcinoma in situ of breast, other/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).